Weakly Supervised Learning-Driven Digital Pathology AI: A Systematic Review from Algorithmic Innovation to Clinical Translation
Technological Pathways and Development · 05.11.2026 · 1 (3)
DOI: 10.70693/xmn1xb07 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Technological Pathways and Development, online erschienen am 05.11.2026. Verfasst von Yuxi Zhu.
Abstract (Originalsprache)
Digital pathology is undergoing a paradigm shift from conventional microscopic diagnosis to computational pathology, with weakly supervised learning (WSL) serving as a key technology for reducing annotation costs. However, a significant gap remains between algorithmic innovation and clinical deployment. Addressing the core question of how WSL can advance digital pathology AI toward clinical use, this review systematically traces the technological evolution of WSL paradigms, clarifies the relationship between pathology foundation models and WSL, and examines the clinical applications and translational bottlenecks of weakly supervised pathology AI. The review indicates that while WSL substantially lowers the annotation cost barrier, the ultimate clinical value still depends on generalization capability, trustworthiness, and real-world validation.
Zitieren
APA
Zhu, Y. (2026). Weakly Supervised Learning-Driven Digital Pathology AI: A Systematic Review from Algorithmic Innovation to Clinical Translation. Technological Pathways and Development, 1(3). https://doi.org/10.70693/xmn1xb07
Vancouver
Zhu Y. Weakly Supervised Learning-Driven Digital Pathology AI: A Systematic Review from Algorithmic Innovation to Clinical Translation. Technological Pathways and Development. 2026;1(3). doi:10.70693/xmn1xb07
BibTeX
@article{Zhu2026,
author = {Zhu, Yuxi},
title = {Weakly Supervised Learning-Driven Digital Pathology AI: A Systematic Review from Algorithmic Innovation to Clinical Translation},
journal = {Technological Pathways and Development},
year = {2026},
volume = {1},
number = {3},
doi = {10.70693/xmn1xb07}
}
EUVIMED